Immunovant (IMVT) Gains as Roivant Sciences Ltd. Explores Takeover

March 8, 2021 9:21 AM EST

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Immunovant (NASDAQ: IMVT) gains 50% pre-open after Roivant Sciences Ltd. discloses in an amended 13D that it has engaged Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and SVB Leerink LLC to serve as its financial advisors in connection with the evaluation of a potential transaction involving the Issuer.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

13Ds, Hot M&A, Mergers and Acquisitions, Rumors

Related Entities

JPMorgan, Goldman Sachs, 13D, Pre Market Movers